Pacific Biosciences of California, Inc.
US ˙ NasdaqGS ˙ US69404D1081

SecurityPACB / Pacific Biosciences of California, Inc.
InstitutionUBS Group AG
UBS Group AG ownership in PACB / Pacific Biosciences of California, Inc.

UBS Group AG has a history of taking positions in derivatives of the underlying security (PACB) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date
Effective
Date
Form Prev
Shares
Latest
Shares
ΔShares
(Percent)
Ownership
(Percent)
ΔOwnership
(Percent)
2018-02-13 2018-02-13 13G/A 5,825,792
2017-02-07 2017-02-07 13G 5,825,792 6.29

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

PACB / Pacific Biosciences of California, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 1,640,099 -1,531,447 -48.29 2,165 -63.51 0.0003
2026-01-29 2025-12-31 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 3,171,546 1,674,320 111.83 5,931 209.50 0.0010
2025-11-13 2025-09-30 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 1,497,226 -495,932 -24.88 1,916 -22.46 0.0003
2025-08-14 2025-06-30 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 1,993,158 -291,120 -12.74 2,472 -8.31 0.0004
2025-05-13 2025-03-31 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 2,284,278 798,263 53.72 2,695 -0.88 0.0005
2025-02-14 2024-12-31 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 1,486,015 843,166 131.16 2,719 148.99 0.0005
2024-11-14 2024-09-30 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 642,849 -186,285 -22.47 1,093 -3.79 0.0002
2024-08-14 2024-06-30 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 829,134 151,881 22.43 1,136 -55.30 0.0003
2024-05-13 2024-03-31 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 677,253 643,359 1,898.15 2,540 664.76 0.0006
2024-02-09 2023-12-31 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 33,894 11,247 49.66 332 75.66 0.0001
2023-11-09 2023-09-30 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 22,647 -207,435 -90.16 189 -93.82 0.0001
2023-08-11 2023-06-30 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 230,082 193,508 529.09 3,060 623.40 0.0010
2023-05-12 2023-03-31 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 36,574 -16,261 -30.78 424 -2.08 0.0002
2023-02-08 2022-12-31 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 52,835 -27,350 -34.11 432 -7.10 0.0002
2022-11-10 2022-09-30 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 80,185 40,554 102.33 465 165.71 0.0002
2022-08-10 2022-06-30 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 39,631 -57,591 -59.24 175 -80.23 0.0001
2022-05-16 2022-03-31 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 97,222 -2,760 -2.76 885 -56.74 0.0003
2022-02-14 2021-12-31 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 99,982 -9,570 -8.74 2,046 -26.90 0.0006
2021-11-15 2021-09-30 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 109,552 -45,756 -29.46 2,799 -48.46 0.0009
2021-08-13 2021-06-30 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 155,308 68,428 78.76 5,431 87.66 0.0018
2021-05-12 2021-03-31 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 86,880 3,996 4.82 2,894 34.60 0.0010
2021-02-11 2020-12-31 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 82,884 45,079 119.24 2,150 476.41 0.0007
2020-11-12 2020-09-30 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 37,805 3,165 9.14 373 213.45 0.0001
2020-07-31 2020-06-30 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 34,640 -112,842 -76.51 119 -73.61 0.0001
2020-05-01 2020-03-31 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 147,482 -1,013,463 -87.30 451 -92.44 0.0002
2020-02-14 2019-12-31 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 1,160,945 -424,207 -26.76 5,967 -27.05 0.0021
2019-11-14 2019-09-30 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 1,585,152 -64,858 -3.93 8,180 -18.06 0.0031
2019-08-14 2019-06-30 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 1,650,010 102,516 6.62 9,983 -10.77 0.0038
2019-05-14 2019-03-31 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 1,547,494 -371,679 -19.37 11,188 -21.22 0.0046
2019-02-14 2018-12-31 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 1,919,173 1,428,246 290.93 14,202 434.71 0.0064
2018-11-14 2018-09-30 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 490,927 100,111 25.62 2,656 91.49 0.0011
2018-08-14 2018-06-30 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 390,816 89,090 29.53 1,387 124.07 0.0006
2018-05-15 2018-03-31 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 301,726 127,112 72.80 619 34.27 0.0003
2018-02-14 2017-12-31 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 174,614 -100,687 -36.57 461 -68.10 0.0002
2017-11-14 2017-09-30 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 275,301 162,066 143.12 1,445 258.56 0.0007
2017-11-14 2017-06-30 13F/A-1 PACIFIC BIOSCIENCES CALIF IN COM 69404D108 113,235 -266 -0.23 403 -31.23 0.0002
2017-08-14 2017-06-30 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 113,235 -266 403
2017-11-14 2017-03-31 13F/A-1 PACIFIC BIOSCIENCES CALIF IN COM 69404D108 113,501 -5,712,291 -98.05 586 -97.35 0.0003
2017-05-12 2017-03-31 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 113,501 -5,712,291 586
2017-02-14 2016-12-31 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 5,825,792 5,745,024 7,113.00 22,138 2,957.73 0.0122
2016-11-14 2016-09-30 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 80,768 -32,630 -28.77 724 -9.27 0.0004
2016-08-12 2016-06-30 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 113,398 105,880 1,408.35 798 1,146.88 0.0005
2016-05-12 2016-03-31 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 7,518 -2,253 -23.06 64 -50.00 0.0000
2016-02-16 2015-12-31 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 9,771 3,556 57.22 128 481.82 0.0001
2015-11-13 2015-09-30 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 6,215 -2,961 -32.27 22 -58.49 0.0000
2015-08-14 2015-06-30 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 9,176 5,976 186.75 53 178.95 0.0000
2015-05-14 2015-03-31 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 3,200 700 28.00 19 -5.00 0.0000
2015-02-17 2014-12-31 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 2,500 2,500 20 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2023-08-11 2023-06-30 13F PACIFIC BIOSCIENCES CALIF IN COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-05-12 2023-03-31 13F PACIFIC BIOSCIENCES CALIF IN COM Call 749,100 8,675 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.